Cancer clinical trials in the region Hauts-de-France

149 currently recruiting clinical trials
Region Hauts-de-France

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
AstraZeneca
Phase 3 Breast cancer
#NCT05232916
HER2 Positive Localized Locally Advanced None Targeted therapy Targeted therapy
Systemic Treatment-Naive Systemic Treatment-Naive
Centre Hospitalier Simone Veil de Beauvais (Beauvais)
Greenwich LifeSciences, Inc.
Phase 3 Lung cancer
#NCT06646276
SCLC (Small Cell Lung Cancer) Locally Advanced Metastatic None Systemic Treatment-Naive
Centre Hospitalier Universitaire de Lille - Institut Cœur Poumon (Lille)
Bristol-Myers Squibb
Phase 3 Kidney cancer
#NCT05678673
Papillary carcinoma Chromophobe carcinoma Other Locally Advanced Metastatic None Systemic Treatment-Naive
Hôpital Claude Huriez (Lille)
Exélixis
Phase 3 Anal cancer
#NCT06207981
Locally Advanced
Radiotherapy Radiotherapy
Institut de Cancérologie des Hauts-de-France - Centre Marie Curie (Arras)
Fédération Francophone de Cancérologie Digestive